Agentic AI in Cancer Research
Are you interested in learning more about “agentic” artificial intelligence (AI)?
Join Drs. Dey, Zou, and Natarajan to gain insights into the emergence of AI system and their perspective on where it’s headed, especially as it relates to cancer research.
Unlike rules-based AI assistants and models, agentic AI has the potential to make autonomous decisions (take action on its own). Instead of waiting for queries or data, agentic AI can autonomously monitor and navigate databases, such as electronic health records, to identify issues and propose solutions.
This webinar is part of the Cancer AI Conversations webinar series. Each event short talks from 2–4 experts who offer diverse perspectives on timely and relevant topics related to AI in cancer research. A moderated panel discussion follows each talk.
Can’t attend an upcoming event? Recordings will be available after each session.
Dr. Dey is a distinguished scientist and the executive director of AI oncology and cancer biology at Genentech.
Dr. Natarajan is a research scientist at Google.
Dr. Zou is an associate professor of biomedical data science at Stanford University.